Unique ID issued by UMIN | UMIN000022358 |
---|---|
Receipt number | R000025776 |
Scientific Title | A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions. |
Date of disclosure of the study information | 2016/05/20 |
Last modified on | 2018/05/23 15:32:09 |
A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.
A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.
A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.
A study on the effect of combining genetic test and plasma amino acid test on promoting health care actions.
Japan |
Metabolic syndrome and cancer
Endocrinology and Metabolism | Hematology and clinical oncology | Adult |
Malignancy
NO
To verify the hypothesis that combining genetic test and plasma amino acid test raises health consciousness and promotes taking health care actions.
Others
survey
Confirmatory
Pragmatic
Not applicable
Analysis on the promoting effect of either single test or combination of genetic test and plasma amino acid test on taking health care actions by questionnaire survey before and 1 month after either test.
Analysis on the promoting effect of the results of genetic and plasma amino acid test on taking health care actions by questionnaire survey before and 1 month after either test.
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
No treatment
NO
NO
No need to know
2
Prevention
Other |
Questionaire survey -> sampling of 5ml blood for amino acid measurement -> Questionnaire survey -> Sampling of saliva for SNP analysis -> Questionnaire survey
Questionnaire survey -> sampling of saliva for SNP analysis -> Questionnaire survey -> Sampling of 5ml blood for amino acid measurement -> Questionnaire survey
25 | years-old | <= |
Not applicable |
Male and Female
Persons who have submitted written informed consent
1)Those who are pregnant, or breast feeding
2)Those who have congenital metabolic disorders
3)Those who are undergoing dialysis
4)Those who are participating in another clinical study
5)Those who have mental diseases or disorders and for whom doctors judged difficult to participate in the study.
6)Those for whom the doctor judged inappropriate to participate in the study.
240
1st name | |
Middle name | |
Last name | Maiko Mori |
Ajinomoto Co., INC.
Institute for Innovation
1-1 Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan
044-210-5828
maiko_mori@ajinomoto.com
1st name | |
Middle name | |
Last name | Nahoko Shikata |
Ajinomoto Co. INC.
Institute for Innovation
1-1 Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan
044-210-5828
nahoko_shikata01@ajinomoto.com
Ajinomoto Co., INC.
Kanagawa Prefecture
Local Government
Japan
Ajinomoto Co., INC.
DeNA Life Science, Inc.
NO
神奈川県予防医学協会(神奈川県)
味の素株式会社(神奈川県)
株式会社DeNAライフサイエンス(東京都)
2016 | Year | 05 | Month | 20 | Day |
Published
http://www.pref.kanagawa.jp/docs/mv4/cnt/f536433/documents/880014.pdf
Combining the genetic testing "MYCODE" and "AminoIndexTM" screening test, based on plasma amino acid profile, raised health consciousness in mind and action compared to having either one of the tests.
Completed
2015 | Year | 10 | Month | 09 | Day |
2015 | Year | 10 | Month | 30 | Day |
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 03 | Month | 31 | Day |
2016 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2016 | Year | 05 | Month | 19 | Day |
2018 | Year | 05 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025776